Full opinion text
RYAN, District Judge. We now approach the task of formulating a final decree designed to prevent and restrain the violations of law which we have found. 15 U.S.C.A. § 4. Our objective is to fashion, in the terms of a decree, means by which the agreement found to exist is terminated, its revival prevented and its effects destroyed by the reestablishment of competitive conditions insofar as they pertain to United States exports and imports. The decree must be based upon the facts as we have found them, and designed to be carried out with a minimum of judicial supervision and control of the future activities of the defendants. Cf. United States v. N. Y. Coffee & Sugar Exchange, 1924, 263 U.S. 611, 44 S.Ct. 225, 68 L.Ed. 475. Where competition • has been eliminated, it must be restored. Only those provisions reasonably necessary to accomplish correction and adjustment of a dislocated competitive situation may be applied. The essence of the violation found was the unlawful agreement to divide world territories. It was this enduring and basic understanding which was fundamental to all of the dealings of the conspirators. It was to accomplish this purpose and end that the various means were adopted. ■ [2] The decree will contain injunctions prohibiting agreements and arrangements between the defendants dividing territory and allocating customers and markets so as to unlawfully limit the commerce of the United States. DuPont shall not be permitted to make agreements restraining their exports throughout the world, and particularly to those markets which have been previously assigned to ICI as its exclusive territory, and to those countries in which the jointly-owned companies functioned. DuPont shall file with the court annually for a period of five years reports showing specifically the nature and, extent of their efforts to increase their foreign trade. We shall retain jurisdiction over all the defendants for a period of five years after the entry of judgment for the purpose of enabling the court to either modify the relief granted or to grant such other or additional relief required to accomplish the purpose of the decree and to terminate the restraints on United States trade and commerce which have been or during that period are found to have been created or imposed by acts of the defendants or any of them. The final decree will contain general injunctive provisions directed to the defendants which are calculated to prevent effectively a continuance or revival of the agreements and understanding between ICI and duPont. The decree, however, must contain additional provisions to implement these injunctive directions, so that they are made probable of observance. The jointly-owned companies and the patents, processes and technologies of the defendants must be brought within the scope of the judgment. , The physical properties and stockholdings in the jointly-owned companies constituted part of the means by which the unlawful agreement to divide world trade was brought to fruition. The restraints sought to be accomplished were achieved also in part by the patents and processes agreements. The patents held by the defendants did not give them control of all the products covered by their understanding; as to many products, control resided in their technology and trade know-how. As to other products, control was possible because of the size of their industrial and selling organizations, and the foothold they enjoyed in the markets divided. This placed them in a position where acting jointly it was possible for them to meet and regulate, if not overcome, the competition offered by others. It was not required of the Government to establish that the defendants had power to control the markets they agreed to divide and allocate, since the suit was filed for violation of Section 1, 15 U.S. C.A. § 1. American Tobacco v. United States, 1946, 328 U.S. 781, 809, 66 S.Ct. 1125, 90 L.Ed. 1575. Although this is so, we must in determining the extent of the restraints give consideration to the position of dominance held by the defendants. We conclude that restraints must be imposed upon not only the exercise of the patent monopolies but also with respect to technology and know-how, as well as their commercial activities. We shall first consider the extent of the relief which is to be granted with respect to patents and technology. While the maintenance of a competitive economy is of prime importance, we may not seek to achieve that end by unwarranted judicial whittling down of patent rights or by the insertion in the decree of provisions for which there is no support in law. We have found that the exchange of patents, processes and know-how served as direct instruments used by the conspirators to achieve their unlawful purpose. A patentee may, if he sees fit, reserve to himself the exclusive use of the discovery or he may license those of his own choice and selection to use it. But evil lies in the illegal use of this lawful right; by concert of action between the conspirators the full and complete exploitation of the patents was prevented by the allocation of territories and agreed restraints placed upon the employment of the patents. The rights of the patentees were exercised for a purpose not intended by our patent laws and in derogation of vested and paramount rights of the public. Such misuse of the patent renders the future use of those rights subject to and amenable to judicial control to prevent a continued or new abuse. The misuse of. a patent may result in denial of relief to the patentee whether he proceeds against a direct or contributory infringer, Katzinger Co. v. Chicago Metallic Mfg. Co., 1947, 329 U.S. 394, 67 S.Ct. 416, 91 L.Ed. 374; but see, Bruce’s Juices v. American Can Co., 1947, 330 U.S. 743, 67 S.Ct. 1015, 91 L.Ed. 1219, on availability of defense of violation of anti-trust law in actions on a contract. In private litigation misuse of patents in anti-trust violation constitutes a defense which may be pleaded; in litigation instituted by the Government such misuse affords basis for injunctive relief of both a restrictive and mandatory nature; in neither may the misuse result in a judgment of forfeiture of all patent rights. “The limited monopolies granted to patent owners do not exempt them from the prohibitions of the Sherman Act and supplementary legislation.” Standard Oil Co. v. United States, 1931, 283 U.S. 163, 169, 51 S.Ct. 421, 423, 75 L.Ed. 926. We do not accept as correct the proposition that compulsory license of United States patents is appropriate only in those instances where required to remove specific restraints upon the manufacture and sale of specified products in the United States caused by the unlawful use of patents to suppress domestic competition. To do so would be to make nugatory the dual aspects of our anti-trust laws, which make unlawful restraints, placed upon our foreign trade as well as our domestic commerce. It is true that in most cases in which compulsory licensing has been decreed, it has been found that the patents have been unlawfully used to suppress domestic competition. Not many actions have been instituted to suppress restraints upon our foreign trade, resulting from agreement among international industrialists to which Americans have made themselves parties. We have had few suits which have presented a situation similar to that revealed here, and which call for remedies we now find necessary. Although no charge has been made of monopolization and no evidence presented to sustain such a charge, we find that the principal defendants are potent factors in the fields in which they have engaged. Their important position, in these industries was such that it made their unlawful understanding not the fanciful dream of wishful entrepreneurs but an existing situation which enabled them to see its accomplishment throughout the world. Here, there was not a mere attempt to allocate territories; restraints upon our foreign trade were in fact accomplished. The Government has asked that compulsory licensing be decreed of future as well as existing patents and technology. The power of the court to direct licensing does not arise in this case from a unilateral decision by a patentee to refrain from using the patent. Such a course, prompted by legal motives would be well within the rights of a patentee. Cf. Special Equipment Co. v. Coe, 1945, 324 U.S. 370, 65 S. Ct. 741, 89 L.Ed. 1006. We decree compulsory licensing because the patent rights which were granted the defendants were misused. The failure to export products manufactured under the patents resulted from the agreement to divide territories. What might have been done lawfully by one, acting as a result •of his own decision, became unlawful because it was brought about by common agreement. The failure to export, which might have been legal in itself, also became unlawful because of the purpose and end it was employed to accomplish. One of the means employed was the patents and processes agreements. The needs and requirements of local markets from which the patentee was excluded by the underlying agreement were met by patent grants to fellow conspirators. Thus, the patent themselves and the right to grant licenses under them were used to implement and ■carry out the allotment of territories. The use of these existing patents must be regulated because of their past abuse. But it does not follow that there is need for the regulation of the use of future patents and future technology. Patents which had not been granted, and technology which had not been developed could not have been put to misuse in the past. We may not act entirely upon an assumption that the defendants will continue in their disregard of the law and violate the injunctions of a final judgment. Cf. Timken Roller Bearing Co. v. United States, 1951, 341 U.S. 593, 604, 71 S.Ct. 971, 95 L.Ed. 1199 We may not take from the defendants all incentive for future endeavour by depriving them in advance of the rewards which might come to them from future patents and technology. Such relief “would discourage rather than encourage competitive research.” United States v. National Lead, 1947, 332 U.S. 319, 359, 67 S.Ct. 1634, 1653, 91 L.Ed. 2077. That the property rights in these patents may be substantial and the incentive and desire of duPont to develop and explore further possibilities is real cannot be disputed. DuPont is spending approximately $45,000,000 a year on research and has recently placed in operation an experimental station costing $30,000,000. Its past development of new products and processes has done much to promote our national economy and to meet the needs and requirements of national defense. We shall impose no unnecessary restrictions to interfere with the continuance of these activities. The evidence also establishes that duPont spent about $45,000,000 on nylon research and has invested $196,800,000 in plants and facilities for nylon production. Although in National Lead compulsory licensing was decreed as to patents “issued to, or acquired by, any of the appellant companies within five years from the date of the decree”, 332 U.S. at page 348, 67 S.Ct. at page 1648, it was limited to a single product — “titanium pigments or any process for the manufacture of such pigments”. In Hartford-Empire Co. v. U. S., 1945, 323 U,S. 386, 65 S.Ct. 373, 89 L.Ed. 322, compulsory licensing was limited in respect to future applications and resulting patents to a group of machines designed to perform particular functions in the glassware industry. 323 U.S. at page 417, 65 S.Ct. 373. In United States v. U. S. Gypsum Co., where the term for compulsory licensing of future patents was left to the discretion of the trial court, a single product was involved — gypsum board. 1950, 340 U.S. 76, 90, 71 S.Ct. 160, 95 L.Ed. 189. To include here the future patents and new processes of large research organizations, sweeping in a vast variety of chemical products, would be punitive as well as destructive of that driving incentive which has accounted for much of the remarkable development of the chemical industry. What patents and technology are we to say then belong to the past and what to the future ? We have had evidence from which we find that the basic understanding, although modified in part was not abandoned in whole, but was continued down to the conclusion of the trial. We fix then, June 30, 1950 as the date which will mark the time between the past and the future for the purpose of our decree and govern those provisions which direct the compulsory licensing of patents and technology. We shall add, however, to these present patents all improvement or new patents in relation to any product with respect to which the defendants are obligated by existing agreement to grant licenses to each other or to third parties, or which are required to be licensed under the terms of our decree. The Government seeks a decree directing the granting of compulsory licensing on a reasonable royalty basis of many of duPont’s and Id’s United States patents; as to the nylon patents, however, it asks for compulsory royalty free licensing. We have had no evidence submitted as to many of the products covered by these patents, or as to the effect of the unlawful use of the vast majority of these patents and technologies. What has been presented has dealt only with the patents and processes agreements, the negotiations which led to them and the operations under them which throw light upon the interpretations given them. Proof as to sales of specific products has -been meagre and confined to a few items. We are therefore not in a position to direct a general compulsory licensing of either patents or technology. We are restricted to those patents and technologies which cover products common in manufacture to both ICI and duPont, or to either of them and any of the jointly owned companies.' Cf. United States v. Paramount Pictures, 1948, 334 U.S. 131, 152, 68 S.Ct. 915, 92 L.Ed. 1260; Schine Chain Theatres v. United States, 1948, 334 U.S. 110, 127-130, 68 S.Ct. 947, 92 L.Ed. 1245. These products were directly subject to the restraints imposed by the basic understanding for the division of world trade. We pause now to note that the various patents and technologies involved were not as a result of the joint efforts of the defendants. Although there was a constant exchange of research progress and an unceasing flow of technical information between the defendants there is no evidence to support the conclusion that either the patents secured or the technology practiced by the defendants came to them as “benefits of their conspiracy.” Schine Chain Theatres v. United States, supra, 334 U.S. at page 128, 68 S.Ct. at page 957. In fact, of three major fields of patents— nylon, polythene and neoprene — quite the contrary is true. Nylon was developed solely by duPont and with great secrecy. It was not until duPont research was well advanced that ICI was first informed of it. Polythene was entirely the product of ICI; the part duPont took in its further development was primarily to aid the joint war effort of the United States and Great Britain, not to advance the unlawful understanding between the defendants. Neoprene was initially licensed by a third party to duPont; IGI did nothing to improve it. We cannot conclude on the proof before us that the duPont and ICI patents were products or results of their unlawful agreement to divide world markets. The validity of no patent was questioned by the Government. For the purposes of this decree we are then encompassed by the factual finding that not only were the patents validly issued but also that they are lawfully owned by the record holders. The power of the court to direct the issuance of royalty free licenses on any of these patents is open to serious question. Cf. Hartford-Empire Co. v. United States, supra, 323 U.S. at pages 413, 414, 65 S.Ct. 373. To provide for the issuance of royalty free licenses with respect to any of these patents would be to destroy the total value of the patent. We find no statutory authority for decreeing such remedies. That the granting of such relief would raise a substantial constitutional question has been recognized. For, it has been written: “That a patent is properly, protected against appropriation both by individuals and by government has long been settled. In recognition of this quality of a patent the courts, in enjoining violations of the Sherman Act arising from the use of patent licenses, agreements, and leases have abstained from action which amounted to a forfeiture of the patents.” Hartford-Empire Co. v. United States, supra, 323 U.S. at page 415, 65 S.Ct. at page 387. It appears that the question of the constitutionality of such a provision was later noted but not passed upon in United States v. National Lead, supra, 332 U.S. at page 349, 67 S.Ct. 1634. It has apparently been the consistent policy of the Government to seek decrees which would in effect nullify the patents which have been used as a means to accomplish the restraints imposed. But in U. S. v. National Lead, D.C., 63 F.Supp. 513, the trial court refused to direct royalty free licenses and this was approved by the Supreme Court. 332 U.S., 353, 359, 67 S. Ct. 1634. In Hartford-Empire, Mr. Justice Roberts writing for the majority struck from the decree of the trial court the provision requiring compulsory royalty free licensing. On at least three occasions the Supreme Court has refused to grant like relief to the Government with respect to know-how. Hartford-Empire Co. v. United States, supra. We would read the Morton Salt Case, (Morton Salt Co. v. C. S. Suppiger Co.) 1942, 314 U.S. 488, 788, 62 S.Ct. 402, 86 L.Ed. 363, and B. B. Chemical Co. v. Ellis, 1942, 314 U.S. 495, 62 S.Ct. 406, 86 L.Ed. 367, as holding not that the patentee lost all right to injunctive relief but only that such relief was to be denied him so long as anti-trust violations continued. Misuse of patent rights does not work a forfeiture of the patent; it only suspends the right of the patentee to obtain judicial relief so long as his misuse ■continues or its effects have not been dis sipated. We do not read either Morton Salt or the Mercoid case (Mercoid Corp. v. Minneapolis Honeywell Reg. Co.), 1944, 320 U.S. 680, 64 S.Ct. 278, 88 L.Ed. 396, as supporting the proposition that a patent is forfeited and the right to royalties destroyed by violation of the antitrust laws. In Morton Salt injunctive relief was denied because the license for the use of a patented machine required the purchase from the licensor for use in the machine of an unpatented article. No evidence was received to sustain a finding that the anti-trust laws had been violated. In Mercoid, although Mr. Justice Douglas wrote that injunctive relief should be denied the patentee because he had violated the anti-trust laws and therefore could not seek equitable relief, the four concurring justices it seems rested their decision on the Morton Salt case and not upon a finding of a violation of the Sherman Act. Hartford-Empire held that reasonable royalty licensing , rather than royalty free licensing was proper. Nor do we interpret the provisions in the Alcoa decree, United States v. Aluminum Co. of America, D.C., S.D.N.Y. 1950, 91 F.Supp. 333, as a ruling contrary to the view that compulsory royalty free licensing is confiscatory. In that case, we find that Alcoa granted the Government royalty free licenses under three basic patents with the right to sublicense also on a royalty free basis. It was also provided Alcoa would receive a non-exclusive royalty free license under any improvement patents developed by the Government or its sub-licensees during the lifetime of the original patents. The decree struck down the grant-back provisions as being impediments to effective competition in the industry. This action, the Government urges as a precedent for the granting of royalty free licenses by decree of a trial court, for it is argued that the only consideration for- the original licensing was the grant-back provisions. However, we observe from study of the record and the decree, first, that the decree does not restrain Alcoa from exacting royalties from those other than the Government to whom it might grant licenses under these same patents in the future and, second, that the striking down of the grant-back provisions did not take from Alcoa its entire consideration and compensation for the licensing grants it had made to the Government. The grants were but part of an entire transaction by which Alcoa acquired from the Government valuable manufacturing facilities. These remained with Alcoa; thus, it was permitted to re-, tain at least part of the consideration for the licenses granted to the Government. We do not accept the Alcoa decree as establishing precedent for the granting of royalty free licenses. We hold that in the circumstances before us, compulsory royalty free licensing may not be decreed in the absence of legislative authority and the sanction of explicit interpretation of existing statutes by higher courts affirmatively permitting such action. An inventor may choose to keep his invention secret, and run the risk of its disclosure, or of having someone else conceive the same idea. 'He balances these chances; when he decides to make application for a patent, he determines to avoid them and to rest in the security of a patent which insures to him the privilege of excluding all others from the practice of the invention for 17 years. When he accepts the special privilege of a patent, he obligates himself to exercise his patent rights in conformity with the law. Misuse of these rights for an unlawful purpose subjects their further use to regulation and control; in this respect patent rights do not differ essentially in character from any other rights which the law creates or recognizes. The power of this court to provide “-further assurance against continued illegal restraints upon interstate and foreign commerce through misuse of these patent rights * * * throügh the compulsory granting to any applicant therefor of licenses at uniform, reasonable royalties under any or all patents defined in the decree”, was settled in National Lead, 332 U.S. at page 348, 67 S.Ct. at page 1648. It was not required of the Government to present proof of specific damage or harm to any competitor as a result of the misuse of the patents by ICI and duPont. The misuse of patents effected a violation of anti-trust legislation; as such it was an offense against public policy and necessarily harmful to a substantial important public interest; “the suppression of competition in international trade is in and of itself a public injury; * * *.” National Lead, 63 F.Supp., at pages 513, 525. We have found that the patents and processes agreements “did, in operation, result in restraints of United States trade.” (Op. p. 203) duPont agreed to restrict its use of United States patents by undertaking not to ship products manufactured under these patents to the territory assigned exclusively to ICI. To make this restriction effective, duPont was also required to impose li-ke limitations on the shipments of anyone whom it might license under its United States patents. Insofar as shipments to Great Britain, were concerned, the restrictions imposed by agreement were further implemented by the granting to ICI of exclusive licenses under the British counterparts of the United States patents. Thus, the exclusionary right under the British patents was applied against imports from the United States, and the basic understanding by which ICI recognized the United States as the exclusive territory of duPont was in turn observed by the granting of an exclusive license to duPont in the United States. This kept the patented products manufactured in the United States out of the market of Great Britain, and the like products manufactured in Great Britain out of the United States. The agreement between ICI and duPont also" brought about a situation by which the United States patents of both were placed in the hands of duPont. This was a pooling of patents for a purpose in restraint of foreign trade. This use of patent fights was condemned in United States v. Line Material Co., 1948, 333 U.S. 287, 311, 68 S.Ct. 550, 92 L.Ed. 701, when employed as a means to effect price fixing arrangements. Line Material was, like the instant suit, brought under Section 1 and neither monopoly nor domination was charged. We have held that when patents are pooled to carry out a division of territories, it is equally as unlawful as when they are unified to effect price fixing. The remedy of compulsory licensing is not to be restricted to monopoly situations. An effect • of compulsory' licensing is to grant to- the public a right to use the patented invention and thus remove^ an impediment to competition. The wrong it'is designed to correct arises from the misuse of lawful patent rights pursuant to an unlawful agreement. Such misuse creates an extension of the patent monopoly. Here, we have had proof of a wrong — unlawful restraints on our trade — accomplished by agreement between ICI and duPont. It was made possible of performance by the voluntary abstention from trade by one in- the exclusive territory of the other, and the restrictive provisions in patent licenses and in technology exchanged. We may hope to compel an abandonment of limitations in the exchange of patents and technology which are used to violate the anti-trust laws only by decreeing that ICI and duPont grant to all others what they have heretofore granted to each other. It may be that the decree will permit them to make better and more profitable terms for the additional grants than they have heretofore demanded inter sese. The result of these restrictions is shown in part by our later observations concerning polythene. It is acknowledged by ICI’s recent investment in Arnold, Hoffman & Company, Inc. of Rhode Island. We are now told that in 1949, ICI’s exports to the United States amounted to a little over $500,000. In I960 with the full force of devaluation, the figure rose to almost $5,-500,000 and in the first nine months of 1951 it stood at over $4,000,000. With a present investment in this company of $5,835,000 IOI contemplates making further loans. The gates shut on our foreign trade have been pried open by this litigation; compulsory licensing will serve to keep them open and promote the flow of foreign trade to and from the United States. We have not made ineffectual the employment of the means ICI has acquired through its investments in Arnold, Hoffman to exploit its future inventions in the United ¡States. We note that this company’s present activities are confined principally to dyestuffs and insecticides; we leave incentive for its further development unimpaired by refusing to grant compulsory licensing of future patents and inventions, save in those cases where ICI is already under obligation to do so to others. The provisions of the belated 1948 agreement eliminate all the patent barriers which might have prevented ICI from exporting patented products to the United States, but these provisions will do no more than tend to increase the competitive potential between ICI and duPont. We are also concerned with increasing th'e possibility of competition between ICI, duPont and others who might desire to enter the field. The unquestionable right of -IOI to determine whether or not it will manufacture under its American patents, to select its licenses, and to determine whether licenses granted shall be exclusive or non-exclusive, has been exercised to implement the allotment of territories. Compulsory licensing will be a cure and not a punishment for this. It has been contended on duPont’s behalf that compulsory licensing should not be decreed because it would not “cause duPont to export and would not affect in any way the result of past failure on the part of duPont to export.” Perhaps this is so, and it leads us to observe that neither would a simple injunctive provision in the decree produce this result. But compulsory licensing will enable others to manufacture and put them in a position where they will be able to export. The application of this remedy might serve as an impetus to a sincere desire on duPont’s part to enter the export field on an active and competitive basis. To us, it seems that an effective method to establish competitive conditions is to decree compulsory licensing of all patents which were licensed among the conspirators and which were put to use in the production of products which were common to some, if not tO' all. It has rightly been observed that “as long as the patentee is free to grant or withhold a patent license at his pleasure, the striking down of one set of restrictive conditions attached to a patent license may lead only to the adoption of another set of conditions which achieve the same effect.” Compulsory Patent Licensing, 56 Yale Law Journal, 1946, p. 82. With the compulsory licensing provisions with respect to patents, there must follow similar licensing provisions with respect to know-how affecting these patents and the products made under them. This must be so because it has been found that the exchange of know-how — as well as that of patents — served as a direct means for the accomplishment of the unlawful restraints; and because the supplying of such know-how and technology is necessary to the efficient use of the licensed patents and to the production by the licensee of products comparable in quality and cost of'production to that of the licensor. The Government has asked that the compulsory licensing of know-how and technology be extended to include all “usable” processes — those processes now being used and applied and those which have been found to be of possible use but which are not currently being applied. The objection to the inclusion of “usable” processes because of difficulties in. ferreting out those processes which have been tried only to be abandoned, and those known to be possible but never used, seems to us more fanciful than real. We have been impressed by the evidence throughout that the defendants function as extremely efficient and competently managed industrial organizations. The records of these “usable” processes will be available to them for disclosure; and it will be so decreed. We have had evidence of three instances when United States manufacturers were denied licensing of ICI’s United States patents because of the intervention and objection of duPont. At trial we deemed these facts to be significant as tending to establish the allocation of the United States as territory to be served exclusively by duPont. Now, we regard them important as indicative of ICI’s undertaking not to exploit its United States patents save through duPont, or by anyone else without the consent of duPont. This was suppressing and controlling competition within the United'States in those products which might have been manufactured under United States patents held by ICI. Accomplished as it was by mutual undertaking in restraint of trade, it was an abuse of the United States patent rights held by ICI ap'd indicates .the necessity for regulation of the- exercise of ICI patent rights. As to those United States patents owned by ICI which have -been voluntarily licensed to others than duPont and on terms no less favorable, there is no present need for compulsory licensing. The patents which have been licensed to and used only by duPont have been subjected to the restraints placed upon exports of products manufactured by them; to remove the probability of future restraints and to correct the effect of past abuse as to these, compulsory licensing must be decreed. ICI owns United States patents whidh have not been licensed either to duPont or others and which ICI itself has not employed in products manufactured here or manufactured elsewhere ’ and imported to the United States. These must also be brought within' the ambit of the compulsory licensing provisions of the decree. Here, too, the provisions will be limited to existing patents as we have defined them. Provision in the decree for compulsory licensing on a reasonable royalty basis does not present an insurmountable obstacle, even though a number of patents may be involved. Difficult and time-consuming problems may be created in determining the royalties, but the answers are there and may be ascertained; difficulties to be encountered in finding these answers do not justify denial of the relief which the established facts require. At least as to polythene and nylon, we have some standards as to reasonable royalties. While it is true that as to them question might well be raised as to- whether they were arrived at after arm’s length commercial negotiations, they do nevertheless furnish guide posts for future determination of the amount at which such royalties should be set. 'But, in any event, as to these products and all others, there is also available for judicial finding the sum a prudent licensee would pay under all existing circumstances. We shall not, however, include in our decree the provision proposed by the Government which purports to limit recoveries in a suit brought against an infringer to reasonable royalties. Such a provision would encourage infringement. The provisions for fixation of reasonable royalties will follow substantially the provisions in anti-trust suits in which similar relief has been decreed and approved by the Supreme Court, National Lead, Gypsum, and Line Material cases. The royalties are to be determined by the court, when agreement has not been privately reached, on petition from the applicant and on proof submitted by the applicant and the defendant involved. The Government does not seek a decree directing ICI to grant compulsory licenses of its British patents. The Government requests that ICI be required to grant immunity under its foreign patents which correspond to the United States patents which we have made subject to compulsory licensing. Such a provision was included in paragraph “7” of the final decree in National Lead, 63 F.Supp., 495, 534, and left undisturbed by the Supreme Court. We have had testimony offered on behalf of ICI by an expert in British law that a provision for granting immunities is contrary to British public policy and that a British court will not enforce such a provision in the judgment of a court of a foreign jurisdiction. As to this, -we observe that, acting on the basis of our jurisdiction in personam, we are merely directing ICI to refrain from asserting rights which it may have in Britain, since the enforcement of those rights will serve to continue the effects of wrongful acts it has committed within the United States affecting the foreign trade of the United States. We are not unmindful that under British law there are restrictions upon exports from the United States by reason of the existence of the British patents owned by ICI. The exclusion of unlicensed imports and the prohibition of unlicensed sales is enforceable because of the legal rights which attach to a British patent. We accept as correct the statements in the brief of ICI that: “Under United States law if a product is patented, sale into the United States of that product constitutes clear infringement of the rights of the American patentee. Such sale will therefore subject the vendor to a suit for infringement even though his acquisition of the patented article abroad (and his use and sale of it there) may be wholly lawful. Boesch v. Graff, 1890, 133 U.S. 697, 10 S.Ct. 378, 33 L.Ed. 787. This is true even though the vendor may hold the foreign patent on the article in question. Daimler Mfg. Co. v. Conklin, 2 Cir., 1909, 170 F. 70, 27 L.R.A.,N.S., 534, certiorari denied, 1910, 216 U.S. 621, 30 S.Ct. 575, 54 L.Ed. 641; T. C. Weygandt Co. v. Van Emden, D.C. S.D.N.Y.1930, 40 F.2d 938. “In the British Empire the law is even more stringent. The owner of a British patent may bar the- importation of any product patented in Great Britain and also 'any product made by any process where the process is patented under British law. It is clear that a patent on a process essential to the production of a product is infringed by sale of an imported product made abroad by that process. Von Heyden v. Neustadt, 1880, 14 Ch.D. 230; United Horse Nail Co. v. Stewart and Co., 1885, 2 R.P.C. 122, 133-134; Saccharin Corp., Ltd. v. Anglo-Continental Chemical Works, Ltd., 1900, 17 R.P.C. 307, 318-319; Terrell, The Law and Practice Relating to Letters Patent for Inventions (London, 1934), pp. 173— 177. “There is no requirement under American law which required duPont to license ICI under its United States patents or ICI to license duPont under its British patents. To the extent that each retained the right under the laws of its respective country to assert patents against imports, this resulted in no limitation upon such imports which in any way exceeded the limitation that would have existed had there been no agreement at all.” But as we have heretofore observed these lawful rights were employed as means to accomplish the unlawful purpose of their underlying agreement. While it is true that these rights exist independent of any provision in the patents and processes agreements, they were granted to ICI by the disclosure or assignment of inventions by duPont pursuant to the terms of these agreements. Inventions were also licensed by ICI to duPont for its exclusive use and exploitation in the United States in accordance with the agreements. In the first instance the patents were employed to restrain duPont’s exports to Great Britain, in plain violation of American anti-trust laws; in the second instance, the patents were used as a means, to prevent ICI exports to the United States and placed a restraint upon the foreign, trade of Great Britain, in violation of her declared policy, if not her laws. It does not seem presumptious for this court to make a direction to a foreign defendant corporation over which it has jurisdiction.to take steps to remedy and correct a situation, which'is unlawful both here and in the foreign jurisdiction in which it is domiciled. Two evils have resulted from the one understanding of ICI and duPont — restraints upon the foreign trade and commerce of the United States as well as on that of Great Britain. It is not an intrusion on the authority of a foreign sovereign for this court to direct that steps be taken to remove the harmful effects on the trade of the United States. We recognize that substantial legal questions may be raised with respect to our power to decree as to duPont’s foreign patents as well as those issued to ICI. Here, we deal with the regulation of the exercise of rights granted by a foreign sovereign to a domestic corporate defendant and to a foreign corporate defendant. Our power so to regulate is limited and depends upon jurisdiction in personam; the effectiveness of the exercise of that power depends upon the recognition which will be given to our judgment as a matter of comity by the courts of the foreign sovereign which has granted the patents in question. Where we have required ICI to grant immunity under British patents which are the counterpart of duPont’s United States patents, the payment of reasonable royalty upon imports of articles manufactured under them into Great Britain shall be paid to ICI. Full recognition is hereby given to the inherent property rights granted by the British patent to exclude from Great Britain merchandise covered by the patent. Since a license under the corresponding United States patent conveys no right to ship into Great Britain articles manufactured in the United States under the patent, no royalty shall be collectible by duPont upon such items as are destined for export to Great Britain. We are advised that the present policy of the British patent law is to foster manufacture in the United Kingdom rather than to permit importation from abroad (12, 13 & 14, George 6 Chapter 87, (Patents Act of 1949); see also Patents and Designs Act of 1907, 25 Halsbury’s Statutes of England, 1932). Sec. 27(2) of the Act of 1909 declared that a British patent would “be deemed to have been abused” if (subsection b), the working of the invention within the United Kingdom on a commercial scale “is being prevented or hindered by the importation from abroad” of the patented article “by the patentee or persons claiming under him,” or by other persons against whom the patentee is not taking proceedings for infringement. Sec. 27, subsec. (b) of paragraph 3 further provides in substance that the comptroller of patents may when such abuse has been established preclude the importation into the United Kingdom of any goods, which in the absence of a license, would be deemed an infringement of the patent. The Patent Act of 1949, carried this public policy further in Sec. 37, to the extent that the comptroller of patents may order a “license of right” when, although the patented invention is capable of being worked in the United Kingdom, it is not being commercially worked “to the fullest extent that is reasonably practicable”, or demand is “not being met on reasonable terms, or is being met to a substantial extent by importation,” or “commercial working of the invention in the United Kingdom is being prevented or hindered by the importation of the patented article” (20th Century Statutes, 1949, vol. 46, p. 1013). The grant of immunity under the British patents would be subject, of course, to the opei'ation of these statutes and proscribed by such action as the comptroller of patents might take. This should not deter us from making directions we feel are required, even thought the application of them be limited in operation by the possible action of an official of a foreign sovereign. It is urged that there is no precedent for these immunity provisions in our decree. It is argued that they are tantamount, because of the limitations imposed by British law, to directing ICI to grant compulsory licenses under British patents. A similar provision by the tidal court, in National Lead, 63 F.Supp. 495, 534, it is said, was not litigated and no point made of it either before the district court or the Supreme Court. 105 F.Supp. 228. It is true that the policy of the British patent laws does not appear to have been specifically called to the trial court’s attention, but from this we may not conclude that it escaped the notice and consideration of the learned and painstaking judge who presided. Nor may we accept the defendant’s observation that the Supreme Court when considering the provisions in National Lead had in mind only the United States patents and that its attention was not focused on the last sen-pence in paragraph “7” of the decree before it, granting immunities under foreign patents. 332 U.S. 319, 336-337, 67 S.Ct. 1634. If this be so, it is better stated by others. We do, however, note that duPont, as here, was among the defendants in National Lead. We have found that nylon was wholly a duPont development to which ICI made no contribution (Op. p. 107). The basic patents covering nylon have not expired. The history of the basic British nylon patents reveals a studied and continued purpose on the part of ICI and duPont to> remove these patents from within the scope of any decree which might ultimately be made by this court (Op. pp. 115, 116, 197, 198). These British patents were issued to duPont. By the agreement of March 30, 1939, ICI received an exclusive license under them; in January, 1940, ICI granted irrevocable and exclusive rights to make nylon yarn from nylon polymer (which is manufactured by ICI) to British Nylon Spinners, Ltd. (BNS). ICI has a stock interest of 50% in BNS, the remaining 50% is held by Courtaulds, Inc. BNS is in the business of manufacturing and distributing nylon yarn. Not content with this arrangement and with the deliberate purpose to “materially reduce the risk of any loss of rights” as a result of this suit (Ex. 708, p. 2705), duPont' pursuant to the nylon agreement of 1946 assigned the basic British nylon patents to ICI. It is now urged that we may not decree with reference to these British patents so as to direct ICI to remove restrictions on imports into Great Britain of nylon polymer or nylon yarn from the United States. It is argued that the sum total of all • these agreements is not to create by itself any restrictions against American imports, and that those which exist arise from the right to be free from competition which is inherent in the British patents and 'cannot possibly be repugnant to the American anti-trust laws. BNS is not. before this court; although they were knowing participants in acts designed to thwart the granting of full relief, we may not direct our decree to them. The lack of .majority stock ownership in ICI likewise prevents control of the future acts of BNS by this means; however, we are not without some remedy still available. Objection is raised by ICI that we are without power to decree that the British nylon patents may not be asserted to prevent the importation of nylon polymer and nylon yarn into Great Britain because BNS has rights which exist independent of those possessed by ICI. This overlooks the circumstances under which BNS acquired its rights to these patents by licenses from ICI. It must be recalled that by the first written agreement between ICI and duPont, of 1939, duPont granted to ICI a license, which was exclusive in those countries designated in the agreement as “ICI exclusive territory” and non-exclusive in what was described as “ICI non-exclusive territory.” (Ex. D. 1153, pp. 7801-2) The agreement further provided that ICI “shall have the free and unrestricted right to grant sub-licenses”, to be known as “manufacturing sub-licenses”, “only upon prior written approval of duPont”; in the event of the granting of these “manufacturing sub-licenses” by ICI, it agreed to secure in writing an undertaking binding the sublicensee as though it had been a party to the agreement between ICI and duPont. It was specifically provided that the sub-licensee “shall obtain no greater rights” than granted to PCI (pp. 7802, 7803). The nylon agreement between duPont and ICI of December 31, 1946, provides in paragraph III (Ex. D. 1163, p. 7869) for the assignment of patents and patent applications listed in Schedule “A” of the agreement in the nylon field. By this writing, ICI became the owner of the British patents, in which its interest up to that time had been that of a licensee. Throughout all these negotiations it appears that BNS was advised of the dealings between ICI and duPont concerning the British nylon patents. Both ICI and duPont are parties to the instant suit; they were advised in fact and realized that the further use and control of the rights pertaining to the British nylon patents were subject to a decree of this court to be entered in this suit. We find that in fact Courtaulds and BNS were also fully advised of this situation. The first, or “manufacturing sub-license” which BNS received granted to it no greater rights than had been acquired by ICI; it was subject to the same infirmities as existed against ICI. The second license granted after the assignment of the patents to ICI did not come to BNS as an innocent party. BNS, again, knew exactly what. it was receiving; its rights are wholly subject to the inherent vices of the agreements through which they were acquired. We have found them to be tainted with the illegality of the unlawful conspiracy; of this probability BNS was informed. The circumstances surrounding the execution of the assignment to- ICI in December, 1946, makes this clear (Op. 198, Ex. 708). It is also recorded that on October 17, 1946, “Courtaulds appreciated the difficulty in which all parties were placed consequent upon the American litigation and were, therefore, willing to accede to a modification of the duPont/I.C.I. Nylon License Agreement” (Ex. D. 2158; p. 11277). On October 28, 1946, Courtaulds undertook to “take all steps in their power to secure that British Nylon Spinners also raise no objection to the conclusion by ICI of the new agreement * * *.” (Ex. D. 2159, p. 11283) We do not hesitate therefore to decree that the British nylon patents may not be asserted by ICI to prevent the importation of nylon polymer and of nylon yarn into Great Britain. What credit may be given to such an injunctive provision by the courts of Great Britain in a suit brought by BNS to restrain such importations we do not venture to predict., We feel that the possibility that the English courts in an equity suit will not give effect to such a provision in our decree should not deter us from including it. In any event it appears that BNS would have the right under Section 63 of the Patents Act of 1949, as the exclusive licensee to bring suit for infringement against an importer of yarn and staple fiber. There would then .be a speedy determination of the effectiveness of the immunity provision of the decree with reference to these products. If the British courts were not to give credit to this provision, no injury would have been done; if the holding of the British courts were to the contrary, a remedy available would not have been needlessly abandoned. Specifically, with relation to nylon, the judgment shall provide that the agreement between duPont and ICI concerning the British nylon patents shall be cancelled; a new agreement may be executed by the parties granting a non-exclusive license, providing for the payment of royalties and removing all contractual barriers to exportation. Those charged by duPont with the direct management and development of nylon are of the opinion that “Immediate steps should be taken toward promoting manufacture of nylon by one or more competent independent concerns through non-exclusive licensing and disposal of know-how.” (Ex. G.J.-l. p. 1) DuPont’s president, C. H. Greenewalt, at a meeting with the Board of Directors of Chemstrand corporation in March, 1950, stated that duPont would also “be willing to consider” granting a license for Fiber V. (Ex. G.J.-2, p. 30). It also appears that “disposal of design and operating information and know-how for nylon spinning wiil put into hands of the purchaser practically everything he needs for successful spinning of Fiber V. * * “ The basic nylon patents on polymerization and spinning of nylon also cover V, e. g., polyamides and polyesters, and so this patent protection expires simultaneously.” (Ex. G.J.-l, p. 13). It is to be noted that Chemstrand is owned jointly by Monsanto Chemical'Company and American Viscose Corporation and was formed for the purpose of exploiting their acrylonitrile fiber. The decision of duPont to license its nylon patents arose entirely from its unwillingness “to accept sole responsibility for supplying the market for nylon textile fibers.” (Ex. G.J.-3, p. 34) Following extended negotiations, on June 2, 1951, duPont undertook for payment of a fixed fee and agreed royalties, to design, procure materials and construct expeditiously a plant for the manufacture of nylon intermediates and nylon yarn, to assist in training of Chemstrand personnel, to provide manuals, and to “disclose to Chemstrand all technical information.” (Ex. G.J.-13, pp. 116-118). We have had no testimony as to whether the Chemstrand agreement embraces patents and processes pertaining to Fiber V or Orion. We assume, therefore, that it does not and that no technical information is “disclosed to to Chemstrand about products or processes not specifically mentioned in the Contract” or of “any product other than a nylon product,” as there defined. (Ex.G.J.-20, p. 185) We accept the Chemstrand agreement as evidence that the compulsory royalty licensing of the nylon patents is feasible. We come then to the 1946 polythene agreement, which regulates the licensing of inventions relating to polythene. This agreement, we have noted (Op. 106), was made two years after the filing of the instant suit; it is still operative. It was drawn with the apparent purpose of bringing the provisions of the agreement within the principle approved in Transparent-Wrap Mach. Corp. v. Stokes Co., 1947, 329 U.S. 637, 647-648, 67 S.Ct. 610, 616, 91 L.Ed. 563, that “Congress, however, has made no specific prohibition against conditioning a patent license on the assignment by the licensee of improvement patents” and “that the inclusion in the license of the condition requiring the licensee to assign improvement patents is not per se illegal and unenforceable.” In that case the court, however, did conclude, “that does not mean that the practice we have here has immunity under the anti-trust laws.” We have found that the negotiations for the polythene agreements were had with the purpose of carrying out the plan to allocate territories and limit competition between ICI and duPont; that purpose continued after the polythene agreement of January, 1946. Polythene, it is not disputed, is within the patents and processes agreements (Op. 106). The provision for grant back of improvement patents perpetuates control of the product, after expiration of the basic patent, for an unlawful use — the division of territories in restraint of United States trade. The fact that a competitor of duPont— Union Carbide and Carbon Chemicals Corporation — is sublicensed under ICI’s basic United States polythene patents does not remove the need for compulsory licensing of these polythene patents. It was apparent from the evidence presented at the trial (Ex. 674), that the sublicense granted to Carbide came about as a result of its- refusal to embark upon the manufacture of polythene and to erect a plant at its own cost under a temporary license , for the period of World War II. The sublicense to Carbide was not born of a desire to put a competitor in the polythene market or of a purpose of ICI to fully exploit its patents in this field in. the United States. The vigorous competition created in this one segment of industry by the relaxing of the ■restraints ICI and duPont placed upon each other, is pointedly illustrated by the performance of Carbide under its sublicense. Carbide has become a far greater factor in the polythene business than duPont. In 1946, Carbide manufactured 7,263,830 lbs. at a net selling price of $3,849,829.90; duPont, in the same period, 1,848,315 lbs. at a net selling price of $977,128.80. This was accomplished although Carbide was subject to a royalty of 5% figured on the selling price, while duPont paid a favored lower rate of royalty. (Ex.D. 1203, p. 7979) This situation continued through the year 1948 (beyond that date we are not informed). Thus, on March 29, 1949, duPont reported to ICI that “Since the signing of the license agreement January 17, 1946, Carbide and Carbon Chemicals Corporation sales and use of Polythene amounted to 30,166,835 pounds on which a royalty of $725,075.67 was paid, while duPont’s sales and use amounted to 7,380,115 pounds, a royalty payment of $121,-746.76, making a combined royalty payment of $846,822.43.” (Ex.D. 1205, p. 7988) Significant, too, is the fact that for the selling quarter of October 1, to December 31, 1948, the net selling price per pound of Carbide was $.4318 (Ex.D. 1205, p. 7989), and of duPont for the same period $.4515 (Ex.D. 1205, p. 7990). We also note that Carbide took a license under ICI basic patents only and uses a process of its own. Carbide has not licensed duPont, and is not licensed by duPont to use its improvement or process patents. The figures afford a graphic example of what might well occur with other products with restraints removed and our anti-trust laws observed! It is clear that the public does have the right to the protection of further competition in this product. _ It is of interest to note that Carbide holds its license under the basic United States polythene patents held by ICI not under a grant from. ICI but as a sublicensee of duPont. (Ex.D. 1199). The sublicense agreement is dated February 8,1946. The license from ICI to duPont is dated January 17, 1946 — only 3 weeks prior. (Ex.D. 1195) It is apparent from these dates that at the time the license was granted by ICI to duPont, there was already in contemplation and in the final stages of negotiation the granting of this sublicense by duPont to Carbide. The latter provided for payment of a cash consideration of $500,000 by Carbide to duPont, and royalties of 5% of the net selling price of untreated polymerized ethylene payable to duPont. j The royalties which are payable by duPont to ICI under its license from ICI are set at a rate graduated according to the amount of poundage produced under its license; starting at 5% of the net selling price of polythene polymers sold in bulk, it is gradually reduced until any excess over 20,000,000 lbs. is subject to a royalty of only 2% (Ex.D. 1195, p. 7939). By the end of 1948, the royalty payable by duPont was in the 2%% bracket. (Ex.D. 1205, p. 7991) But Carbide pays a straight 5% royalty irrespective of the total amount of sales throughout the period of license. (Ex. D. 1199, p. 7967). Although duPont is required to pay over to ICI the excess in royalties it receives from Carbide, it was permitted to retain the cash payment of $500,000. (Ex.D. 1195, p. 7939). Carbide is compelled to operate at a selling price disadvantage as compared with duPont. And, beyond this, Carbide is required to “keep a separate record of polymerized ethylene manufactured and used or sold by Carbide,” and to permit duPont accountants to examine these books and records “from time to time during business hours.” (Ex.D. 1199, pp. 7967-8). DuPont may thus keep a watch and check on the activities of its competitor in the polythene field. This does not present a very pretty picture of competitive conditions when establsihed by the joint action of ICI and duPont, not under judicial decree. While this might have resulted from the proper and lawful exercise of patent rights, we have found that the grant to duPont in the first instance to practice the invention was an abuse of the patent. This situation is a consequence of that abuse; it operated to place Carbide in a distinctly disadvantageous position, if and when, Carbide might seek to export its polythene products from the United States. This polythene sublicense to Carbide by duPont is of greater significance when viewed in the light of prior dealings between duPont and ICI on the matter of sublicenses granted 'by one on an invention which originated with the other. As early as November, 1931, the Standard Oil Company made inquiry of ICI concerning the possibility of securing a license from ICI under one of its United States patents covering dyestuffs. When the matter was taken up by ICI with duPont the director of du~ Pont’s Foreign Relations Department in a memorandum to the Executive Committee set forth duPont’s position with relation to the granting of sublicenses by one on the patents of the other in the following language, “Under the Agreement, Paragraph IX, it is provided that no sub-license shall be granted by any licensee without the consent, in writing, first obtained from the original licensor. There is, we believe, no misunderstanding on this point between ICI and ourselves. ICI’s suggestion, however, that they would be ready to discuss with us terms for Standard to acquire a sub-license, raises an inference with which we disagree. It is our feeling that once having granted us an exclusive license to a patent, the patent is entirely our property and if we decided to issue a sub-license under it, after first obtaining ICI’s permission, the terms are entirely for us to decide and any revenue which might